Entero Therapeutics ( (ENTO) ) has released a notification of late filing.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Entero Therapeutics, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The delay is primarily due to the complex accounting treatment required for their recent acquisition of GridAI Corp. The company is ensuring that the financial statements are accurately presented according to relevant accounting standards. Entero Therapeutics anticipates filing the delayed report no later than the fifth calendar day following the original due date. The company does not expect any significant changes in financial results from the corresponding period last year. Entero Therapeutics is committed to maintaining compliance, as indicated by the signature of Anna Skowron, the Interim Chief Financial Officer, on the notification.
More about Entero Therapeutics
Average Trading Volume: 217,456
Technical Sentiment Signal: Hold
Current Market Cap: $5.99M
Find detailed analytics on ENTO stock on TipRanks’ Stock Analysis page.